Status:
COMPLETED
Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma
Lead Sponsor:
Alcon Research
Conditions:
Open-angle Glaucoma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study was to evaluate the safety and intraocular pressure (IOP)-lowering efficacy of anecortave acetate for treatment of elevated IOP in patients with open-angle glaucoma.
Eligibility Criteria
Inclusion
- Diagnosis of open-angle glaucoma;
- Other protocol-defined inclusion criteria may apply.
Exclusion
- Pseudoexfoliation;
- Pigment dispersion component;
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT00451152
Start Date
March 1 2007
End Date
July 1 2009
Last Update
November 28 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Texas
San Antonio, Texas, United States, 78257